Divi's Laboratories Limited (DIVISLAB) — Board Meeting Announcement

· NSE 🟡 Notable Neutral
📢 Key Event
Board recommends ₹30 dividend per share for FY2025-26, payable post-AGM on August 10, 2026.
🔄 What Changed
Proposed dividend of ₹30 per share (1,500% payout) for FY2025-26, up from prior year's ₹20.
🔮 What's Next
Dividend to be paid after August 14, 2026, contingent on AGM approval on August 10, 2026.
💡 Investor Takeaway
Shareholders must submit tax forms by July 24, 2026, to avoid 20% TDS on dividend income.

Divi's Laboratories announced a ₹30 per share dividend for FY2025-26, payable after August 14, 2026, to shareholders on record as of July 24, 2026, subject to AGM approval on August 10, 2026, with mandatory tax withholding documentation required by July 24, 2026, detailing resident and non-resident tax rules, forms like Form 121, and submission via KFintech portals.

📄 View Original Announcement (PDF)

About Divi's Laboratories Limited (DIVISLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,79,470.03 Cr P/E: 72.4 ROE: 16.6% ROCE: 22.1%

View full DIVISLAB stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.